What Is Spirulina and How Does It Work?
Spirulina is a type of cyanobacterium (blue-green algae) that grows in freshwater and saltwater environments. It is one of the oldest life forms on Earth and has been consumed as a food source for centuries in several cultures. Today it is widely sold as a powder or tablet supplement.
Spirulina is notable for its high protein content — it is approximately 60–70% protein by dry weight (Karkos et al., 2011). It also contains the pigment phycocyanin, which has antioxidant properties, along with B vitamins, iron, and gamma-linolenic acid (GLA).
Proposed mechanisms
Spirulina's main hypothesised benefits operate through several pathways:
- Antioxidant activity via phycocyanin inhibiting lipid peroxidation
- Anti-inflammatory action potentially via suppression of certain pro-inflammatory pathways
- Lipid modulation through possible effects on cholesterol and triglyceride metabolism
What the RCT and Meta-Analysis Evidence Shows
A systematic review and meta-analysis by Serban et al. (2016) pooled data from randomised trials and found that spirulina supplementation was associated with significant reductions in total cholesterol and LDL-cholesterol compared to placebo (Serban et al., 2016). Triglycerides were also reduced, and HDL-cholesterol showed a modest improvement in some trials.
For blood pressure, the same meta-analysis by Serban et al. (2016) found that spirulina significantly reduced both systolic and diastolic blood pressure in hypertensive individuals.
Regarding antioxidant capacity, a randomised trial by Park et al. (2008) in older adults found that spirulina supplementation improved markers of antioxidant status and also improved haematological variables suggestive of better iron status (Park et al., 2008).
Effect Sizes and Who Benefits
The lipid and blood pressure effects shown in trials are biologically meaningful. People who may see the most benefit from spirulina include:
- Individuals with mildly elevated cholesterol or triglycerides
- Individuals with modestly elevated blood pressure
- Older adults seeking support for antioxidant status
Spirulina is not a replacement for cardiovascular medication or lifestyle interventions. The protein content — while high proportionally — is modest at typical supplementation amounts and should not be the primary reason to choose it over conventional protein sources.
EFSA-Approved Claims
EFSA has not authorised specific health claims for spirulina as a supplement in the EU. Products cannot legally claim to treat high cholesterol or hypertension. Marketing must remain within permissible boundaries.
Honest Verdict
Spirulina has a more solid evidence base than many "superfood" supplements. The lipid and blood pressure findings from meta-analyses are credible. However, effect sizes are meaningful for people who need lipid or blood pressure support, not for healthy individuals seeking general wellness. Quality control is important when buying spirulina — contamination with cyanotoxins has been reported in poorly manufactured products.
Browse spirulina options at maxfit.ee in the spirulina category.
FAQ
Does spirulina help lower cholesterol?
A meta-analysis of randomised trials found significant reductions in total cholesterol and LDL-cholesterol with spirulina supplementation. The effect is most relevant for people with mildly elevated baseline levels.
Is spirulina a complete protein?
Spirulina contains all essential amino acids and has a high protein content by dry weight. However, the total protein per typical daily dose is modest — it is not a practical primary protein source.
How do I choose a quality spirulina supplement?
Look for products that have been third-party tested for cyanotoxins and heavy metals. Certifications from recognised bodies and sourcing from reputable producers reduce contamination risk.
References
Karkos, P. D., Leong, S. C., Karkos, C. D., Sivaji, N., & Assimakopoulos, D. A. (2011). Spirulina in clinical practice: evidence-based human applications. Evidence-Based Complementary and Alternative Medicine, 2011, 531053. https://doi.org/10.1093/ecam/nen058
Serban, M. C., Sahebkar, A., Dragan, S., Stoichescu-Hogea, G., Ursoniu, S., Andrica, F., & Banach, M. (2016). A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clinical Nutrition, 35(4), 842–851. https://doi.org/10.1016/j.clnu.2015.09.007
Park, H. J., Lee, Y. J., Ryu, H. K., Kim, M. H., Chung, H. W., & Kim, W. Y. (2008). A randomized double-blind, placebo-controlled study to establish the effects of spirulina in elderly Koreans. Annals of Nutrition & Metabolism, 52(4), 322–328. https://doi.org/10.1159/000151486
